JHC
TNXP icon

Jones Hill Capital’s Tonix Pharmaceuticals TNXP Stock Holding History

Jones Hill Capital’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.98M Buy
625,428
+173,312
+38% +$2.24M 1.7% 19
2026
Q1 		$6.22M Buy
+452,116
New +$6.96M 1.33% 19

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jones Hill Capital's TNXP Position: Q2 2026 in Review

Jones Hill Capital increased its Tonix Pharmaceuticals (TNXP) stake by 38% in Q2 2026, buying an estimated $2.24M and bringing the position to 625,428 shares worth $7.98M. The position accounts for 1.7% of the portfolio, ranked #19.

Jones Hill Capital first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Jones Hill Capital held 625,428 shares of Tonix Pharmaceuticals worth $7.98M as of Q2 2026.
  • Jones Hill Capital bought 173,312 Tonix Pharmaceuticals shares in Q2 2026, an estimated $2.24M.
  • Tonix Pharmaceuticals made up 1.7% of Jones Hill Capital's portfolio in Q2 2026, its #19 holding.
  • Jones Hill Capital first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Jones Hill Capital's 13F filing for Q2 2026, filed 13 Aug 2026.